Vaginal Atrophy and genitourinary symptoms of menopause – Your questions answered: Part 1

Expert/s: Dr Terri Foran
   Rated 5 / 5 stars

Save

CPD for this activity

Educational Activities (EA)

0.5 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0.5 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0.5 mins

Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0.5 mins

Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.

MO
0 mins

Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.

Listen to the episode

Description

In this episode:

  • Vaginal oestrogen is safe at any age, including over 70, with regular review
  • Use vaginal oestrogen cautiously in younger women; rule out other causes such like vulval dermatitis
  • In breast cancer survivors, vaginal oestrogen is off-label; prefer estriol and involve oncology
  • Vaginal DHEA (Intrarosa) is effective with minimal absorption; lacks long-term safety data; no washout needed when switching

 

The questions answered in this podcast are listed below.
They were compiled by GPs and health professionals around Australia who attended Healthed’s face-to-face seminars.

  1. What are the main symptoms for women with vaginal atrophy, and what is the general approach when a woman comes to talk about these symptoms?
  2. How long can women use vaginal oestrogen for?
  3. If you saw a woman over the age of 70, would you feel comfortable allowing her to continue using vaginal oestrogen?
  4. Is it safe to use vaginal oestrogen in a younger woman who might be breastfeeding or taking the combined oral contraceptive pill and experiencing vaginal dryness or discomfort?
  5. Do you need to take the same precautions for side effects as you would with systemic hormone therapy? For example, if there was a woman who was prone to venous thromboembolism (VTE), is it safe for her to use vaginal oestrogen?
  6. Is there any role for vaginal oestrogen in reducing the frequency of recurrent genital herpes outbreaks?
  7. Are there situations where you would use vaginal oestrogen in combination with a non-hormonal product for better results?
  8. Thoughts on laser treatments, microneedling, or PRP for vaginal or vulval symptoms?
  9. In women who present with urethral caruncles, is there a role for vaginal oestrogen as part of the treatment? How long would you try using vaginal oestrogen for that?
  10. What about the doses of oestrogen when treating someone who’s had breast cancer? What do we have to be mindful of? 
  11. What about women with a history of endometrial, cervical, or vulval cancer? Can we use vaginal oestrogen if they’ve got symptoms?
  12. Can DHEA (Intrarosa) be used safely in women with a history of cancer?
  13. For women without breast cancer, when would you use DHEA instead of oestrogen?
  14. Would you ever use both oestrogen and DHEA together?
  15. What about using DHEA in conjunction with systemic menopausal hormone therapy?
  16. Are there any thoughts around the improvements in libido with the use of DHEA?
  17. If you had tried someone on Ovestin (estriol) and wanted to switch to Intrarosa, is a washout period required before starting?

 

Expert: Dr Terri Foran, Sexual Health Physician

Host: Marita long, GP and Medical Educator

Total time: 33 mins

 

Last Updated: 29 May, 2025

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Scientia Prof Henry Brodaty AO

Scientia Prof Henry Brodaty AO

Donanemab – A GP Guide to Anti-Amyloid Therapies

Prof Andrew Sindone

Prof Andrew Sindone

LDL and Cardiovascular Disease

Dr Sonia Davison

Dr Sonia Davison

Early Menopause

A/Prof Daryl Efron

A/Prof Daryl Efron

Autism Spectrum Disorder in Children

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Terri Foran

expert

Dr Terri Foran

Sexual Health Physician; Conjoint Senior Lecturer, School of Women’s and Children’s Health, UNSW

Recent articles

Find your area of interest

Share this

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease